BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer (Q64140220)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer |
clinical trial |
Statements
A Phase Ib/II Randomized Study of BI 836845 in Combination With Exemestane and Everolimus Versus Exemestane and Everolimus Alone in Women With Locally Advanced or Metastatic Breast Cancer (English)
0 references
15 May 2014
0 references
25 November 2016
0 references
164
0 references
18 year
0 references
99 year
0 references